These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines. Staprans SI; Feinberg MB Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S5-32. PubMed ID: 15285703 [TBL] [Abstract][Full Text] [Related]
26. First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: progress in first and second order studies. Warren JT; Dolatshahi M J Med Primatol; 1993; 22(2-3):203-35. PubMed ID: 8411110 [No Abstract] [Full Text] [Related]
27. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys. Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628 [TBL] [Abstract][Full Text] [Related]
28. Fourth annual survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates. Warren JT; Levinson MA J Med Primatol; 1995 May; 24(3):150-68. PubMed ID: 8751055 [No Abstract] [Full Text] [Related]
30. Vaccines that stimulate T cell immunity to HIV-1: the next step. McMichael AJ; Koff WC Nat Immunol; 2014 Apr; 15(4):319-22. PubMed ID: 24646598 [TBL] [Abstract][Full Text] [Related]
31. An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS. Wang SW; Bertley FM; Kozlowski PA; Herrmann L; Manson K; Mazzara G; Piatak M; Johnson RP; Carville A; Mansfield K; Aldovini A AIDS Res Hum Retroviruses; 2004 Aug; 20(8):846-59. PubMed ID: 15320989 [TBL] [Abstract][Full Text] [Related]
32. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins. Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331 [TBL] [Abstract][Full Text] [Related]
33. Preparation and induction of immune responses by a DNA AIDS vaccine. Smith JM; Leung NJ; Torres JV Viral Immunol; 2000; 13(3):343-51. PubMed ID: 11016598 [TBL] [Abstract][Full Text] [Related]
34. Preclinical AIDS vaccine development: formal survey of global HIV, SIV, and SHIV in vivo challenge studies in vaccinated nonhuman primates. Warren JT; Levinson MA J Med Primatol; 1997; 26(1-2):63-81. PubMed ID: 9271191 [No Abstract] [Full Text] [Related]
35. A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity. Someya K; Xin KQ; Matsuo K; Okuda K; Yamamoto N; Honda M J Virol; 2004 Sep; 78(18):9842-53. PubMed ID: 15331719 [TBL] [Abstract][Full Text] [Related]
37. Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates. Warren JT; Dolatshahi M J Med Primatol; 1994; 23(2-3):184-225. PubMed ID: 7966234 [No Abstract] [Full Text] [Related]
38. Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Demberg T; Robert-Guroff M Int Rev Immunol; 2009; 28(1):20-48. PubMed ID: 19241252 [TBL] [Abstract][Full Text] [Related]
39. HIV vaccines--where are we going? Heilman CA; Baltimore D Nat Med; 1998 May; 4(5 Suppl):532-4. PubMed ID: 9585205 [No Abstract] [Full Text] [Related]
40. Why do we not have an HIV vaccine and how can we make one? Burton DR; Moore JP Nat Med; 1998 May; 4(5 Suppl):495-8. PubMed ID: 9585194 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]